Is a complete STO/ONCOZ research report available?

No complete published report is available for sto/ONCOZ (STO/ONCOZ) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

STO/ONCOZ (STO/ONCOZ)

Nasdaq Stockholm: STO/ONCOZ · SEK

SEK 6.57

-0.23 (-3.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-08-02 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first STO/ONCOZ analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	92.3M
Revenue (ttm)	71K
Net income (ttm)	-23.1M
EPS (ttm)	-SEK 1.85
Shares out	14M
Volume	28,470
Beta	1.35

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 71K
Net income (ttm): -23.1M
EPS (ttm): -SEK 1.85
Market cap: 92.3M

All STO/ONCOZ indicators

Market & fundamental data

Available fields

157

Groups with data

Currency

SEK

Showing 157 of 157 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	1
Employees Change	-1%
Employees Change Percent	-50
Enterprise value	SEK 98.9M
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Biotechnology
Isin	SE0015504097
Last refreshed	2026-08-02
Market cap	SEK 92.3M
Price	SEK 6.57
Price currency	SEK
Rev Per Employee	71,000x
Sector	Healthcare
Sector PE	751.3
Sector PE Fwd	26.73
Sic	2834
Symbol	sto/ONCOZ
Website	https://oncozenge.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-25.05%
P/B ratio	257.81x
P/S ratio	1,299.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-26,985%
EBITDA Margin	-26,985%
Gross margin	100%
Gross Profit	SEK 71,000
Gross Profit Growth	-97.38%
Gross Profit Growth3 Y	228.66%
Net Income	SEK -23.1M
Net Income Growth Years	0%
Pretax Margin	-32,557.75%
Profit Per Employee	SEK -23.1M
ROA	-120.2
Roa5y	-29.96
ROCE	-412.1
ROE	-446.6
Roe5y	-76.59
ROIC	-158.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-1.65%
Cagr3y	20.55%
Cagr5y	-12.83%
EPS Growth Years	0
Revenue Growth	-97.38x
Revenue Growth Years	1x
Revenue Growth3 Y	228.66x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0.01
Assets	SEK 11.8M
Cash	SEK 935,000
Current Assets	SEK 5M
Current Liabilities	SEK 3.9M
Debt	SEK 7.5M
Debt Equity	SEK 20.95
Equity	SEK 358,000
Interest Coverage	-64.89
Liabilities	SEK 11.4M
Long Term Assets	SEK 6.9M
Long Term Liabilities	SEK 7.5M
Net Cash	SEK -6.6M
Net Cash By Market Cap	SEK -7.11
Net Debt Equity	SEK 18.34
Tangible Book Value	SEK -6.5M
Tangible Book Value Per Share	SEK -0.46
WACC	11.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.26
Net Working Capital	SEK 73,000
Quick ratio	0.69
Working Capital	SEK 1M
Working Capital Turnover	SEK 0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.89%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-1.65%
200-day SMA	6.17
3Y total return	75.2%
50-day SMA	7.03
50-day SMA vs 200-day SMA	50over200
5Y total return	-49.66%
All Time High	17.6
All Time High Change	-62.67%
All Time High Date	2021-02-15
All Time Low	1.6
All Time Low Change	310.63%
All Time Low Date	2023-08-25
ATR	0.55
Beta	1.35
Beta1y	1.02
Beta2y	1.1
Ch YTD	-2.81
High	6.86
High52	10.28
High52 Date	2025-12-09
High52ch	-36.09%
Low	6.28
Low52	4.52
Low52 Date	2026-01-22
Low52ch	45.52%
Ma50ch	-6.54%
Price vs 200-day SMA	6.45%
RSI	43.79
RSI Monthly	52.25
RSI Weekly	51.29
Sharpe ratio	0.26x
Sortino ratio	0.5
Total Return	-6.89%
Tr YTD	-2.81
Tr1m	-9.13%
Tr1w	-4.23%
Tr3m	9.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -22.6M
Operating margin	-31,877.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,915,285%
Net Borrowing	7,500,000
Shares Insiders	39.07%
Shares Institutions	13.53%
Shares Out	14,048,068
Shares Qo Q	4.92%
Shares Yo Y	6.89%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	17,928.8x
Bv Per Share	0.03
Ch1m	-9.13
Ch1w	-4.23
Ch1y	-1.65
Ch3m	9.5
Ch3y	75.2
Ch5y	-49.66
Ch6m	26.59
Change	-3.38%
Change From Open	-1.05
Close	6.8
Days Gap	-2.35
Dollar Volume	187,047.9
Earnings Date	2026-09-03
EBIT	SEK -32.4M
EBITDA	SEK -32.4M
EPS	SEK -1.85
F Score	1
Financing CF	20,982,000
Fiscal Year End	December
Founded	2,020
Is Primary Listing	1
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Ma150	6.3
Ma150ch	4.32%
Ma20	6.83
Ma20ch	-3.76%
Net CF	-359,000
Next Earnings Date	2026-09-03
Open	6.64
Position In Range	50
Price Date	2026-07-31
Relative Volume	1.67x
Revenue	71,000x
Tr6m	26.59%
Volume	28,470
Z Score	-14.11

STO/ONCOZ (STO/ONCOZ)

Coverage state: Market snapshot only — no published research

Generate the first STO/ONCOZ analysis

Price

Financial snapshot

Fair-value bridge

Latest news · STO/ONCOZ

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All STO/ONCOZ indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on STO/ONCOZ

Frequently asked questions